 |
Suramin |
|---|---|
| Trade Name | Metaret |
| Orphan Indication | Hormone-refractory prostate cancer |
| USA Market Approval | USA |
| USA Designation Date | 1997-05-06 00:00:00 |
| Sponsor | Warner-Lambert Company;Parke-Davis Pharmaceutical Research Division, 2800 Plymouth Road;Ann Arbor, Michigan, 48105 |
